Results 241 to 250 of about 2,525,913 (309)
Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba +5 more
wiley +1 more source
Estimating Regional Demand for Mechanical Thrombectomy Based on Daily Case Distribution. [PDF]
Ohta T +4 more
europepmc +1 more source
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David +12 more
wiley +1 more source
Dynamics and Forecasting of Emergency Department Presentations: An Integrative Approach Based on Statistical Analysis and Time-Series Models. [PDF]
Sas LM +7 more
europepmc +1 more source
Propagating shocks and transitions across networked food systems: Insights from multiplayer microeconomic modeling. [PDF]
Zaitchik BF +6 more
europepmc +1 more source
Transport-capacity thresholds for urban nutrition security under extreme food-supply disruptions: evidence from Shanghai. [PDF]
Zhang H, Jiang Q.
europepmc +1 more source
Diffusion dynamics of technological innovations in health: the case of an innovative medical imaging technology in France. [PDF]
Guignard R, Geffroy B, Fernandez V.
europepmc +1 more source

